Comparison of clinicopathologic, cosmetic and quality of life outcomes in 700 oncoplastic and conventional breast-conserving surgery cases: A single-centre retrospective study.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
02 2019
Historique:
received: 24 06 2018
revised: 01 09 2018
accepted: 09 09 2018
pubmed: 26 10 2018
medline: 21 3 2019
entrez: 25 10 2018
Statut: ppublish

Résumé

Limited data is available from studies that directly compare oncoplastic breast surgery and conventional breast-conserving surgery (CBCS) procedures. The aim of this study was to compare three volume displacement oncoplastic breast-conserving surgery (OBCS) techniques to CBCS procedures, providing more evidence and facilitating the standardization of OBCS techniques. A retrospective single-centre comparative study was performed between January 2010 and January 2017 involving 758 breast cancer patients. The endpoints for comparison were oncological safety, frequency of complications, initiation time of adjuvant therapy, aesthetic outcome, quality of life and operation time. To compare data, statistical analyses were performed. The mean follow-up time was 51 months for the OBCS group and 52 months for the CBCS group. The excised weight of the specimens was significantly larger in the OBCS group than in the CBCS group (90 g vs. 63 g). The overall complication rate (5.7% vs. 6.6%), the initiation time of adjuvant therapy (4.2 weeks vs. 4.1 weeks) and the local recurrence rate (2.0% vs. 3.7%) did not differ significantly. Scores for the aesthetic outcome were significantly higher in the OBCS group; however, required longer operation time. The investigated OBCS procedures allowed the removal of large volumes of breast tissue with improved cosmetic outcomes without delay in adjuvant therapies, maintaining the oncological safety. However, OBCS required longer operation time. Furthermore, the extended radicality of the OBCS could reduce the rate of re-excision and completion mastectomy, although it may result in the overtreatment of some breast cancer patients.

Identifiants

pubmed: 30352766
pii: S0748-7983(18)31424-0
doi: 10.1016/j.ejso.2018.09.006
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-124

Informations de copyright

Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

Péter Kelemen (P)

Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: dr.kelemenp@gmail.com.

Dávid Pukancsik (D)

Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: d.pukancsik@gmail.com.

Mihály Újhelyi (M)

Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: ujmisi@gmail.com.

Ákos Sávolt (Á)

Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: drsavolt@hotmail.com.

Eszter Kovács (E)

Department of Radiological Diagnostics, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: koveszt5@gmail.com.

Gabriella Ivády (G)

Department of Surgical and Molecular Pathology, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: iv.gabi@gmail.com.

István Kenessey (I)

National Cancer Registry, National Institute of Oncology, Ráth György Str. 7-9., 1122, Budapest, Hungary; 2(nd) Department of Pathology, Semmelweis University, Üllői Str. 93., 1091, Budapest, Hungary. Electronic address: steveken12@yahoo.com.

Tibor Kovács (T)

Department of Breast Surgery, Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, United Kingdom. Electronic address: tiborkovacsdr@yahoo.co.uk.

Alexia Stamatiou (A)

School of Medicine, Semmelweis University, Üllői Str. 26, 1085, Budapest, Hungary. Electronic address: alexiastamatiou@gmail.com.

Viktor Smanykó (V)

Department of Radiotherapy, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: smanykov@yahoo.com.

Zoltán Mátrai (Z)

Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: matraidoc@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH